SARS-CoV-2 has rapidly spread across the globe and infected hundreds of millions of
people worldwide. As our experience with this virus continues to grow, our understanding of …

Although respiratory failure and hypoxaemia are the main manifestations of COVID-19,
kidney involvement is also common. Available evidence supports a number of potential …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the pathogen
responsible for the coronavirus disease 2019 (COVID-19) pandemic, which has resulted in …

There is growing evidence that coronavirus disease 2019 (COVID-19) can lead to a
dysregulation of the immune system with the development of autoimmune phenomena. The …

Kidney involvement in patients with coronavirus disease 2019 (COVID-19) is common, and
can range from the presence of proteinuria and haematuria to acute kidney injury (AKI) …

In December 2019, a novel coronavirus was isolated from the respiratory epithelium of
patients with unexplained pneumonia in Wuhan, China. This pathogen, named severe acute …

Many patients with SARS-CoV-2 infection develop neurological signs and symptoms;
although, to date, little evidence exists that primary infection of the brain is a significant …

Background COVID-19 is a deadly pulmonary disease with peculiar characteristics, which
include variable clinical course and thrombophilia. A thorough understanding of the …

Background Naming a newly discovered disease is a difficult process; in the context of the
COVID-19 pandemic and the existence of post-acute sequelae of SARS-CoV-2 infection …

Importance Acute kidney injury (AKI) occurs in up to half of patients hospitalized with
coronavirus disease 2019 (COVID-19). The longitudinal effects of COVID-19–associated AKI …